228. 閉塞性細気管支炎
[臨床試験数:92,薬物数:125(DrugBank:34),標的遺伝子数:33,標的パスウェイ数:152]
Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02543073 (ClinicalTrials.gov) | September 2014 | 4/9/2015 | MSC for Treatment of Interstitial Lung Disease After Allo-HSCT | Mesenchymal Stem Cell for Treatment of Interstitial Lung Disease After Allogenetic Hematopoietic Stem Cell Transplantation | Lung Diseases, Interstitial;Hematopoietic Stem Cell Transplantation;Bronchiolitis Obliterans | Biological: MSCs;Drug: AZM;Drug: Glucocorticoid | Nanfang Hospital of Southern Medical University | Sun Yat-sen University | Recruiting | 18 Years | 65 Years | All | 60 | Phase 1;Phase 2 | China |